/PRNewswire/ -- eFFECTOR Therapeutics, a newly established biopharmaceutical company, today announced the completion of a $45 million Series A... ...
http://in.advfn.com/p.php?pid=nmona&article=57644195/PRNewswire/ -- Janssen Research & Development, LLC (Janssen) announced that data related to three Janssen Oncology compounds have been selected... ...
http://www.asianhhm.com/news/news_archives.asp?NewsID=45390